Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Clinical trial NCT01255462 · COMPLETED
Trial details
- NCT number
- NCT01255462
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2011-09-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.